Sort   by:  
 Page size 
UnknownAssociation Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).
Not available
S-EPMC5012711 | biostudies-literature
UnknownNovel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
Not available
S-EPMC6235897 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
UnknownGenome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
Not available
S-EPMC4557485 | biostudies-literature
UnknownCell-type-specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes.
Not available
S-EPMC6211648 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownGenome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.
Not available
S-EPMC7255059 | biostudies-literature
UnknownInteraction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
Not available
S-EPMC8756361 | biostudies-literature
UnknownSurvival and Neurodevelopmental Outcomes among Periviable Infants.
Not available
S-EPMC5456289 | biostudies-literature
UnknownDeep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function.
Not available
S-EPMC12878677 | biostudies-literature
Sort   by:  
 Page size